Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy of LAS41005 Compared to Placebo and to LAS106521 in the Treatment of Actinic Keratosis Grade I to II

NCT00987246 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT00987246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy of LAS41005 Compared to Placebo and to LAS106521 in the Treatment of Actinic Keratosis Grade I to II
Lead sponsor
Almirall, S.A.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
June 30, 2009
Enrollment
470 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis